Angiotensin-converting enzyme gene polymorphism and middle cerebral artery stenosis in a Chinese Han population

Chunshu Rong1, Yingqi Xing2, Xinmei Jiang2

  • 1Department of Encephalopathy, Affiliated Hospital of Changchun University of Chinese Medicine, Changchun 130021, Jilin Province, China ; Department of Neurology, First Hospital of Jilin University, Changchun 130021, Jilin Province, China.

Neural Regeneration Research
|September 11, 2014
PubMed

Insights

This study investigated the angiotensin-converting enzyme gene

Area of Science:

  • Genetics
  • Neurology
  • Cardiovascular Research

Background:

  • The angiotensin-converting enzyme (ACE) gene is implicated as a potential stroke risk factor.
  • Middle cerebral artery stenosis (MCAS) is a significant cause of ischemic stroke.

Purpose of the Study:

  • To investigate the association between ACE gene polymorphisms (DD genotype and D allele) and MCAS in a Han Chinese population.
  • To explore the role of ACE as a genetic marker for stroke risk in MCAS patients.

Main Methods:

  • Genotyping of the ACE gene was performed using PCR-restriction fragment length polymorphism (PCR-RFLP) analysis.
  • Peripheral blood samples were collected from 148 MCAS patients and 62 healthy controls.
  • Frequencies of ACE genotypes and alleles were compared between patient and control groups.

Main Results:

  • The frequencies of the ACE DD genotype and D allele were numerically higher in MCAS patients compared to healthy controls.
  • However, these observed differences in genotype and allele frequencies did not reach statistical significance.
  • No significant correlation was found between ACE gene variants and MCAS in this North China Han population.

Conclusions:

  • The ACE gene DD genotype and D allele are not significantly associated with middle cerebral artery stenosis in the studied Han population.
  • Further research is warranted to explore the synergistic effects of multiple stroke candidate genes on MCAS.
  • This study provides a foundation for future investigations into gene therapy for stroke prevention and treatment.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
80
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.2K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
155
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
2.0K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K